Clinical Trial Update: A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) [Phase 1, Phase 2]

View source ↗

Summary

An early-phase clinical trial evaluating I-DXd in combination with atezolizumab, with or without carboplatin, as first-line induction or maintenance therapy for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• I-DXd

Snippet

Sponsor: Daiichi Sankyo | Conditions: Extensive Stage-small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING